|
CP 376395 盐酸盐
|
C287406-50mg
|
≥99%(HPLC) |
1013933-37-3 |
50mg
|
¥ 9075.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
CP 376395 盐酸盐
|
C287406-10mg
|
≥99%(HPLC) |
1013933-37-3 |
10mg
|
¥ 2256.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
CYM 5520,S1P2变构激动剂
|
C287402-50mg
|
Moligand™, ≥99%(HPLC) |
1449747-00-5 |
50mg
|
¥ 3577.9
|
现货 |
|
0 |
阿拉丁 |
|
CYM 5520,S1P2变构激动剂
|
C287402-10mg
|
Moligand™, ≥99%(HPLC) |
1449747-00-5 |
10mg
|
¥ 1462.9
|
现货 |
|
0 |
阿拉丁 |
|
CP 93129 二盐酸盐
|
C287389-10mg
|
≥98% |
879089-64-2 |
10mg
|
¥ 1859.9
|
现货 |
|
0 |
阿拉丁 |
|
CP 43,TAOK抑制剂
|
C287360-50mg
|
≥98%(HPLC) |
850467-66-2 |
50mg
|
¥ 1159.9
|
现货 |
|
0 |
阿拉丁 |
|
CP 43,TAOK抑制剂
|
C287360-10mg
|
≥98%(HPLC) |
850467-66-2 |
10mg
|
¥ 323.9
|
现货 |
|
0 |
阿拉丁 |
|
CL 82198 盐酸盐
|
C287353-50mg
|
≥98%(HPLC) |
1188890-36-9 |
50mg
|
¥ 725.9
|
现货 |
|
0 |
阿拉丁 |
|
CL 82198 盐酸盐
|
C287353-10mg
|
≥98%(HPLC) |
1188890-36-9 |
10mg
|
¥ 406.9
|
现货 |
|
0 |
阿拉丁 |
|
CCMI,α7nAChRs的正变构调节剂
|
C287349-50mg
|
≥98% |
917837-54-8 |
50mg
|
¥ 1297.9
|
现货 |
|
0 |
阿拉丁 |
|
CCMI,α7nAChRs的正变构调节剂
|
C287349-10mg
|
≥98% |
917837-54-8 |
10mg
|
¥ 572.9
|
现货 |
|
0 |
阿拉丁 |
|
8-氯腺嘌呤核苷
|
C287342-50mg
|
≥98%(HPLC) |
34408-14-5 |
50mg
|
¥ 4699.9
|
现货 |
|
0 |
阿拉丁 |
|
8-氯腺嘌呤核苷
|
C287342-10mg
|
≥98%(HPLC) |
34408-14-5 |
10mg
|
¥ 1499.9
|
现货 |
|
0 |
阿拉丁 |
|
(±)-Clopidogrel hydrochloride
|
C287321-50mg
|
≥99%(HPLC) |
130209-90-4 |
50mg
|
¥ 4448.9
|
现货 |
|
0 |
阿拉丁 |
|
(±)-Clopidogrel hydrochloride
|
C287321-10mg
|
≥99%(HPLC) |
130209-90-4 |
10mg
|
¥ 1417.9
|
现货 |
|
0 |
阿拉丁 |
|
CX 614,AMPA受体的正变构调节剂
|
C287317-50mg
|
Moligand™, ≥98% |
191744-13-5 |
50mg
|
¥ 793.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
CX 614,AMPA受体的正变构调节剂
|
C287317-10mg
|
Moligand™, ≥98% |
191744-13-5 |
10mg
|
¥ 449.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
CP 31398 二盐酸盐
|
C287282-50mg
|
≥95% |
1217195-61-3 |
50mg
|
¥ 647.9
|
现货 |
|
0 |
阿拉丁 |
|
CP 31398 二盐酸盐
|
C287282-10mg
|
≥95% |
1217195-61-3 |
10mg
|
¥ 188.9
|
现货 |
|
0 |
阿拉丁 |
|
CD 2665,RARβ/γ拮抗剂
|
C287183-50mg
|
Moligand™, ≥98%(HPLC) |
170355-78-9 |
50mg
|
¥ 8693.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
CD 2665,RARβ/γ拮抗剂
|
C287183-10mg
|
Moligand™, ≥98%(HPLC) |
170355-78-9 |
10mg
|
¥ 2400.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
CE3F4,非竞争性Epac1抑制剂
|
C287179-50mg
|
Moligand™, ≥98%(HPLC) |
143703-25-7 |
50mg
|
¥ 3148.9
|
现货 |
|
0 |
阿拉丁 |
|
CE3F4,非竞争性Epac1抑制剂
|
C287179-10mg
|
Moligand™, ≥98%(HPLC) |
143703-25-7 |
10mg
|
¥ 898.9
|
现货 |
|
0 |
阿拉丁 |
|
CC4,亚型α6β2和α4β2nAChR部分激动剂
|
C287130-50mg
|
≥98%(HPLC) |
492-02-4 |
50mg
|
¥ 6345.9
|
期货,请咨询 |
|
0 |
阿拉丁 |